Introduction Methods
 A total of 4,724 IVF cycles were incorporated into the analysis.
 If Bemfola were used across all of these cycles instead of the respective gonadotrophin, drug wastage would be reduced by 376,800IUs and there would be an associated cost saving of £100,011.
 Extrapolating these data to the annual number of UK IVF cycles results in a potential cost saving of £1,157,579.
Gonal-f wastage versus Bemfola
 Of the 4,078 Gonal-f cycles, overall drug wastage was 650,775IU (5.7% of the total dose prescribed [ 
Results

Conclusion Limitations
 Using Bemfola as an alternative to Gonal-f or Menopur can potentially reduce drug wastage and associated costs to both patients and the NHS.  Extrapolation of these results to the number of cycles conducted annually in the UK assumes that Menopur or Gonal-f are used for all IVF cycles and in equal proportions to that seen in the five clinics included in the analysis.
 List prices were used to calculate cost savings when in reality products are offered at discounts. The relative % difference in wastage and therefore cost saving between products will however, remain the same regardless of the price used. 
